November 20, 2025

New study finds U.S. fluoride exposure linked to better adolescent cognitive performance 

A new study finds typical childhood fluoride exposure is linked to modestly better teen cognitive performance with no later cognitive harm.

ADA News

November 20, 2025

ADA urges Senate Finance Committee to include oral health in national health cost reforms 

The ADA outlined priorities for addressing cost drivers and improving oral health care access in a letter to the Senate Finance Committee.

ADA News

November 19, 2025

ADA calls for oral health integration in federal chronic disease care coordination efforts 

The ADA is urging lawmakers to include oral health in efforts to modernize care coordination for chronic disease prevention and treatment. 

ADA News

November 19, 2025

Cognitive Function and Statin Administration During Doxorubicin-Based Cancer Treatment

Contrary to previous research, a preplanned secondary analysis of the multicenter PREVENT trial, reported by W.Gregory Hundley, MD, FACC, of Pauley Heart Center, Division of Cardiology, Department of ...

The ASCO Post

November 19, 2025

FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma

On November 6, 2025, the U.S. Food and Drug Administration approved daratumumab and hyaluronidase-fihj (Darzalex Faspro) for adults with high-risk smoldering multiple myeloma.

The ASCO Post

November 19, 2025

FDA Approves Selumetinib for Adults With NF1 With Symptomatic, Inoperable Plexiform Neurofibromas

The MEK inhibitor was approved today for adults with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas. In September 2025, the FDA approved selumetinib capsules a...

The ASCO Post

November 19, 2025

New Study Explores Why Male Patients With AML May Have Worse Outcomes

New research has ruled out hormone signaling as the reason why men with AML tend to have poorer outcomes than women, even when treated with the same intensive chemotherapy—a finding that helps refine ...

The ASCO Post

November 19, 2025

Lung Cancer Treatment Evolutions Include Surgical Innovation and Molecular Targeted Therapy

Lung cancer survival rates have approximately doubled over the past two decades — a remarkable achievement driven by convergent advances in early detection, surgical technique and molecular oncology.

Baptist Health South Florida

November 19, 2025

Project ASCENT: Advancing Lung Cancer Screening in Hispanic Populations

Lung cancer remains the leading cause of cancer mortality in the United States, surpassing the combined deaths of breast, colon and prostate cancers.

Baptist Health South Florida